Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

Multimedia

Headshot of Raymond Douglas on a blue background underneath the PopHealth Perspectives logo.
Podcasts
07/28/2021
Maria Asimopoulos
Raymond Douglas, MD, PhD, director of the orbital and thyroid eye disease program, Cedars-Sinai Medical Center, discusses the treatment efficacy of Tepezza (teprotumumab) in a variety of patients with thyroid eye disease, including how this...
Raymond Douglas, MD, PhD, director of the orbital and thyroid eye disease program, Cedars-Sinai Medical Center, discusses the treatment efficacy of Tepezza (teprotumumab) in a variety of patients with thyroid eye disease, including how this...
Raymond Douglas, MD, PhD,...
07/28/2021
Population Health
Headshot of Richard Parker on a blue background underneath the PopHealth Perspectives logo.
Podcasts
07/27/2021
Maria Asimopoulos
Richard Parker, MD, chief medical officer, Arcadia, discusses trends in COVID-19 vaccination rates, explains how Arcadia has been using technology to support patient outreach, and makes recommendations for other health care organizations...
Richard Parker, MD, chief medical officer, Arcadia, discusses trends in COVID-19 vaccination rates, explains how Arcadia has been using technology to support patient outreach, and makes recommendations for other health care organizations...
Richard Parker, MD, chief...
07/27/2021
Integrated Healthcare Executive
Headshot of Jeffrey Stark on a blue background underneath the PopHealth Perspectives logo.
Videos
07/26/2021
Maria Asimopoulos
Jeffrey Stark, MD, head of immunology medical affairs, UCB, breaks down the unique challenges patients with psoriasis face, and discusses the BE RADIANT and BE SURE studies, both of which indicated that bimekizumab was effective at achieving...
Jeffrey Stark, MD, head of immunology medical affairs, UCB, breaks down the unique challenges patients with psoriasis face, and discusses the BE RADIANT and BE SURE studies, both of which indicated that bimekizumab was effective at achieving...
Jeffrey Stark, MD, head of...
07/26/2021
First Report Managed Care
Headshot of Chris Clark on a blue background underneath the PopHealth Perspectives logo.
Podcasts
07/22/2021
Maria Asimopoulos
Chris Clark, global head of asset and commercial strategy, rare diseases, UCB, discusses UCB’s expanded efforts to treat patient populations with rare diseases, including UCB’s work on two investigational treatments for myasthenia gravis.
Chris Clark, global head of asset and commercial strategy, rare diseases, UCB, discusses UCB’s expanded efforts to treat patient populations with rare diseases, including UCB’s work on two investigational treatments for myasthenia gravis.
Chris Clark, global head of...
07/22/2021
First Report Managed Care
Headshot of Dr Efstathios Kastritis on a blue background underneath the PopHealth Perspectives logo.
Videos
07/12/2021
Maria Asimopoulos
Efstathios Kastritis, MD, associate professor of clinical therapeutics/medical oncology, National and Kapodistrian University of Athens, School of Medicine, discusses the findings of the ANDROMEDA study, a phase 3 clinical study that...
Efstathios Kastritis, MD, associate professor of clinical therapeutics/medical oncology, National and Kapodistrian University of Athens, School of Medicine, discusses the findings of the ANDROMEDA study, a phase 3 clinical study that...
Efstathios Kastritis, MD,...
07/12/2021
Population Health
Headshot of Gregg Sylvester on a blue background underneath the PopHealth Perspectives logo.
Podcasts
06/14/2021
Gregg Sylvester, MD, MPH, chief medical officer, Seqirus, explains why the use of Fluad (Influenza Vaccine, Adjuvanted) was more effective than non-adjuvanted standard dose trivalent influenza vaccine for reducing the risk of all-cause...
Gregg Sylvester, MD, MPH, chief medical officer, Seqirus, explains why the use of Fluad (Influenza Vaccine, Adjuvanted) was more effective than non-adjuvanted standard dose trivalent influenza vaccine for reducing the risk of all-cause...
Gregg Sylvester, MD, MPH, chief...
06/14/2021
Annals of Long-Term Care
Headshot of Dr Gil Melmed on a blue background underneath the PopHealth Perspectives logo.
Podcasts
06/01/2021
Julie Gould
In an effort to bring more awareness to Clostridioides difficile, Gil Melmed, MD, gastroenterologist, Cedars Sinai, Los Angeles, breaks down the typical treatment regimen for this patient population, reviews treatment guidelines, and...
In an effort to bring more awareness to Clostridioides difficile, Gil Melmed, MD, gastroenterologist, Cedars Sinai, Los Angeles, breaks down the typical treatment regimen for this patient population, reviews treatment guidelines, and...
In an effort to bring more...
06/01/2021
First Report Managed Care
Addressing Common LTACH Misconceptions and Understanding Average Admission Length Related to Insurance Coverage
Podcasts
05/20/2021
Sean Muldoon, MD, MPH, FCCP, SVP and chief medical officer, Hospital Division, Kindred Hospitals, identifies the major differences between long-term acute care hospitals vs traditional hospitals, and compares the varied admission lengths for...
Sean Muldoon, MD, MPH, FCCP, SVP and chief medical officer, Hospital Division, Kindred Hospitals, identifies the major differences between long-term acute care hospitals vs traditional hospitals, and compares the varied admission lengths for...
Sean Muldoon, MD, MPH, FCCP, SVP...
05/20/2021
First Report Managed Care
Debatable Topics in Oncology Pharmacy: New Meeting to Offer Insight for Pharmacists
Podcasts
05/17/2021
Chris Fausel, PharmD, MHA, BCOP, clinical manager, oncology pharmacy, Indiana University Health, and co-chair of the new Great Debates & Updates in Oncology Pharmacy, discusses this new program for pharmacists that highlights 15 topics,...
Chris Fausel, PharmD, MHA, BCOP, clinical manager, oncology pharmacy, Indiana University Health, and co-chair of the new Great Debates & Updates in Oncology Pharmacy, discusses this new program for pharmacists that highlights 15 topics,...
Chris Fausel, PharmD, MHA, BCOP,...
05/17/2021
Pharmacy Learning Network
Headshot of Heidi Arthur, chief campaign development officer, Ad Council, on a dark blue background
Podcasts
05/11/2021
Heidi Arthur, chief campaign development officer, Ad Council, discusses a new video series featuring pharmacists that is aimed at improving COVID-19 vaccine efforts and also helps pharmacists answer some of the most commonly asked questions.
Heidi Arthur, chief campaign development officer, Ad Council, discusses a new video series featuring pharmacists that is aimed at improving COVID-19 vaccine efforts and also helps pharmacists answer some of the most commonly asked questions.
Heidi Arthur, chief campaign...
05/11/2021
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement